Anatara Lifesciences Ltd (ANR.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 1.67 Million AUD | 17.76% |
| 2023 | 1.41 Million AUD | -19.7% |
| 2022 | 1.76 Million AUD | -59.15% |
| 2021 | 4.32 Million AUD | 29.4% |
| 2020 | 3.34 Million AUD | -47.61% |
| 2019 | 6.38 Million AUD | -34.96% |
| 2018 | 9.81 Million AUD | -20.33% |
| 2017 | 12.31 Million AUD | -11.52% |
| 2016 | 13.91 Million AUD | 147.34% |
| 2015 | 5.62 Million AUD | -24.5% |
| 2014 | 7.45 Million AUD | 10209.22% |
| 2013 | 72.3 Thousand AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q4 | 1.67 Million AUD | 0.0% |
| 2024 FY | 1.67 Million AUD | 17.76% |
| 2024 Q2 | 1.43 Million AUD | 0.0% |
| 2023 Q4 | 1.41 Million AUD | 0.0% |
| 2023 FY | 1.41 Million AUD | -19.7% |
| 2023 Q2 | 1.95 Million AUD | 0.0% |
| 2022 Q4 | 1.76 Million AUD | 0.0% |
| 2022 Q2 | 3.12 Million AUD | 0.0% |
| 2022 FY | 1.76 Million AUD | -59.15% |
| 2021 Q2 | 5.04 Million AUD | 0.0% |
| 2021 Q4 | 4.32 Million AUD | 0.0% |
| 2021 FY | 4.32 Million AUD | 29.4% |
| 2020 Q2 | 4.78 Million AUD | 0.0% |
| 2020 FY | 3.34 Million AUD | -47.61% |
| 2020 Q4 | 3.34 Million AUD | 0.0% |
| 2019 FY | 6.38 Million AUD | -34.96% |
| 2019 Q4 | 6.38 Million AUD | 0.0% |
| 2019 Q2 | 7.9 Million AUD | 0.0% |
| 2018 Q2 | 10.8 Million AUD | 0.0% |
| 2018 FY | 9.81 Million AUD | -20.33% |
| 2018 Q4 | 9.81 Million AUD | 0.0% |
| 2017 Q2 | 13.5 Million AUD | 0.0% |
| 2017 Q4 | 12.31 Million AUD | 0.0% |
| 2017 FY | 12.31 Million AUD | -11.52% |
| 2016 FY | 13.91 Million AUD | 147.34% |
| 2016 Q2 | 12.96 Million AUD | 0.0% |
| 2016 Q4 | 13.91 Million AUD | 0.0% |
| 2015 Q2 | 6.54 Million AUD | 0.0% |
| 2015 FY | 5.62 Million AUD | -24.5% |
| 2015 Q4 | 5.62 Million AUD | 0.0% |
| 2014 FY | 7.45 Million AUD | 10209.22% |
| 2014 Q4 | 1.05 Million AUD | 0.0% |
| 2014 Q3 | 1.05 Million AUD | 0.0% |
| 2013 FY | 72.3 Thousand AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AdAlta Limited | 5.57 Million AUD | 70.009% |
| Acrux Limited | 8.96 Million AUD | 81.352% |
| Race Oncology Limited | 20.22 Million AUD | 91.737% |
| Biome Australia Limited | 8.27 Million AUD | 79.806% |
| Botanix Pharmaceuticals Limited | 112.46 Million AUD | 98.514% |
| BTC Health Limited | 5.14 Million AUD | 67.538% |
| Chimeric Therapeutics Limited | 15.27 Million AUD | 89.056% |
| CSL Limited | 56.93 Billion AUD | 99.997% |
| Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 98.919% |
| Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 99.277% |
| EZZ Life Science Holdings Limited | 25.55 Million AUD | 93.459% |
| Hexima Limited | 2.26 Million AUD | 26.337% |
| Immutep Limited | 147.44 Million AUD | 98.866% |
| Memphasys Limited | 12.43 Million AUD | 86.553% |
| Neuren Pharmaceuticals Limited | 247.97 Million AUD | 99.326% |
| Noxopharm Limited | 6.78 Million AUD | 75.361% |
| Prescient Therapeutics Limited | 20.39 Million AUD | 91.804% |
| Radiopharm Theranostics Limited | 72.03 Million AUD | 97.68% |
| Starpharma Holdings Limited | 36.81 Million AUD | 95.46% |
| Tissue Repair Ltd | 19.38 Million AUD | 91.38% |
| Biotron Limited | 493.47 Thousand AUD | -238.704% |
| Alterity Therapeutics Limited | 19.22 Million AUD | 91.305% |
| Bio-Gene Technology Limited | 3.15 Million AUD | 47.1% |
| Zelira Therapeutics Limited | 5.18 Million AUD | 67.754% |
| Patrys Limited | 4.16 Million AUD | 59.837% |
| Orthocell Limited | 26.61 Million AUD | 93.72% |
| Imugene Limited | 151.39 Million AUD | 98.896% |
| PYC Therapeutics Limited | 91.23 Million AUD | 98.168% |
| Proteomics International Laboratories Limited | 10.87 Million AUD | 84.631% |
| Cynata Therapeutics Limited | 8.38 Million AUD | 80.074% |
| Arovella Therapeutics Limited | 13.28 Million AUD | 87.418% |
| Nanollose Limited | 241.95 Thousand AUD | -590.81% |
| Invex Therapeutics Ltd | 6.12 Million AUD | 72.689% |
| NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | 69.252% |
| Amplia Therapeutics Limited | 14.84 Million AUD | 88.741% |
| Island Pharmaceuticals Limited | 2.56 Million AUD | 34.824% |
| Nyrada Inc. | 5.9 Million AUD | 71.706% |
| Telix Pharmaceuticals Limited | 398.3 Million AUD | 99.58% |
| Dimerix Limited | 32.07 Million AUD | 94.79% |
| PharmAust Limited | 11.12 Million AUD | 84.976% |
| AnteoTech Limited | 9.38 Million AUD | 82.183% |
| Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | 93.898% |
| Recce Pharmaceuticals Ltd | 6.36 Million AUD | 73.759% |
| Avecho Biotechnology Limited | 7.31 Million AUD | 77.164% |
| Actinogen Medical Limited | 21.31 Million AUD | 92.157% |
| Immuron Limited | 15.54 Million AUD | 89.251% |
| Argenica Therapeutics Limited | 16.37 Million AUD | 89.794% |